|Jong-Won Choi||Joint Chief Executive Officer||N/A||N/A||1967|
|Ho-Suk Chon||Joint Chief Executive Officer||N/A||N/A||1958|
|Seok-Yong Choi||Chief Operating Officer and Senior Managing Director||N/A||N/A||1962|
Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
Hyundai Bioscience Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.